← All Ultralife CORP filings

Ultralife CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ULBI
Ultralife CORP
10-K/A: Ultralife Corporation Files Amendment to Annual Report
Ultralife Corporation has filed an amendment to its Form 10-K for the fiscal year ended December 31, 2025, to include omitted Part III information.
NASDAQ
ULBI
Ultralife CORP
10-K: Ultralife Reports 2025 Net Loss Amid Rebranding, Strong Backlog
Ultralife Corporation reported a net loss of $5.9 million for 2025, driven by a significant non-cash intangible asset impairment from a global rebranding initiative, despite robust revenue growth and record backlog in its Battery & Energy Products segment.
NASDAQ
ULBI
Ultralife CORP
10-K/A: Ultralife Corporation Files Amendment No. 1 to Form 10-K, Providing Additional Corporate Governance and Executive Compensation Details
Ultralife Corporation files an amendment to its annual report on Form 10-K to include information on directors, executive officers, corporate governance, and executive compensation.
NASDAQ
ULBI
Ultralife CORP
10-K: Ultralife Corporation Reports FY 2024 Results, Driven by Battery & Energy Products Growth
Ultralife Corporation's FY 2024 results show revenue growth driven by the Battery & Energy Products segment, offset by a decline in Communications Systems sales.
NASDAQ
ULBI
Ultralife CORP
10-K/A: Ultralife Corporation Files Amendment No. 1 to Annual Report on Form 10-K
Ultralife Corporation has filed an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
ULBI
Ultralife CORP
10-K: Ultralife Corporation Reports Fiscal Year 2023 Results, Revenue Up 20.3%
Ultralife Corporation's annual report reveals a 20.3% increase in revenue for fiscal year 2023, driven by growth in both Battery & Energy Products and Communications Systems segments.